55KRC: UC expert discusses ADHD
According to the Centers for Disease Control and Prevention, millions of children in the United States have been diagnosed with attention-deficit/hyperactivity disorder (ADHD).
The University of Cincinnati's Jenni E. Farrow, MD, recently was a guest on 55KRC's Simply Medicine program and podcast to discuss ADHD.
Farrow explained the chronic neurodevelopmental disorder can be one of three types: predominantly inattentive, predominantly hyperactive or a combined type of both. About 85% of children diagnosed will continue with ADHD through adolescence, and about 50% to 70% will have a recurrent, remitting course of ADHD through adulthood, according to Farrow.
"The thing about ADHD is we think about the core symptoms of inattention, hyperactivity, interrupting, intruding, all of that, but there’s a lot of emotion dysregulation that goes with it that can create lots of kind of interpersonal conflict and just difficulties feeling successful, you know, in relationships and in the classroom," said Farrow, adjunct assistant professor in the Department of Psychiatry and Behavioral Neuroscience in UC's College of Medicine. "So it can really erode self esteem over time. So I believe it’s really important to be evaluated and be treated if appropriate."
Treatments include medication, behavioral therapy and practical positive reinforcements that create environments that reduce distractions, Farrow said.
Listen to the Simply Medicine interview. (Note: Segment begins around 0:31 mark.)
Featured photo at top courtesy of Unsplash.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.